Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-18-001032
Filing Date
2018-05-11
Accepted
2018-05-10 18:06:29
Documents
4
Period of Report
2018-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 11036
2 NEWS RELEASE DATED MAY 10, 2018 ex991.htm EX-99.1 5836
3 GRAPHIC image_001.jpg GRAPHIC 1972
4 GRAPHIC image_002.jpg GRAPHIC 683
  Complete submission text file 0001279569-18-001032.txt   21822
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 18824366
SIC: 2834 Pharmaceutical Preparations